Menu
Du musst dich anmelden oder registrieren, bevor du fortfahren kannst.
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Resmed Inc. sell Wolfe Research

Start price
€218.20
18.09.24 / 50%
Target price
€161.78
18.09.25
Performance (%)
6.92%
End price
€233.30
19.09.25
Summary
This prediction ended on 19.09.25 with a price of €233.30. The SELL prediction by Wolfe_Research shows the price for Resmed Inc. slightly increased by 6.92% during the runtime of the prediction. A total of €1.00 was paid as dividends for this prediction. Wolfe_Research has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Resmed Inc. -2.451% -2.451% -5.414%
iShares Core DAX® 0.734% 1.458% 17.980%
iShares Nasdaq 100 -2.686% -0.146% 3.810%
iShares Nikkei 225® -2.261% -2.729% 11.679%
iShares S&P 500 -1.346% 0.467% 1.970%

Comments by Wolfe_Research for this prediction

In the thread Resmed Inc. diskutieren
Prediction Sell
Perf. (%) 6.92%
Target price 161.784
Change
Ends at 18.09.25

ResMed Inc. (NYSE: RMD) had its "underperform" rating re-affirmed by analysts at Wolfe Research. They now have a $180.00 price target on the stock.
Ratings data for RMD provided by MarketBeat

In the thread Trading Resmed Inc.
Prediction Sell
Perf. (%) 6.92%
Target price 161.784
Change
Ends at 18.09.25

Die von Wolfe_Research gewählte maximale Laufzeit wurde überschritten